In Pennsylvania – where prescription overdose is a leading cause of death among young people – doctors are pushing for access to the state’s prescription monitoring program, which tracks Schedule II controlled substances. Currently, the database can only be accessed by law enforcement officials, but a new proposal would open up the information to doctors and pharmacists. Most state drug-monitoring programs already give access to health providers, but patient privacy concerns have hampered doctors’ access to Pennsylvania’s database, according to the article.
Meanwhile, Florida – which implemented its prescription drug monitoring program in September – has seen a growing number of physicians using the database, even though they are not yet required by law to do so. In that state, legislation has been introduced to take it a step further by requiring prescribers to consult the database and review the patient’s history before writing prescriptions for certain drugs, according to this article.